Nano Holdings,Inc.

4571

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-07FY2027 Q1

Revenue

2100M JPY

YoY +2529.8%

Operating Income

-2.8100M JPY

YoY -45.4%

Net Income

-10.2100M JPY

YoY -16.4%

EPS

-3.4JPY

YoY -18.9%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

2.6億円

-3.2億円

-9億円

-14.8億円

-20.6億円

Rev: 2.6億円Op: -20.6億円NI: -18.8億円

Rev: 2億円Op: -12.5億円NI: -13.1億円

Rev: 1.4億円Op: -8.6億円NI: -7.8億円

Rev: 1.1億円Op: -7.6億円NI: -8.4億円

Rev: 1.7億円Op: -9.7億円NI: -9.4億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress35M

Revenue Forecast-

Net Income Progress-2.800M

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan